FATE Stock Analysis Overview
What this means: Fate Therapeutics (FATE) gets an Overall Rank of 53, which is an above average rank under InvestorsObserver's stock ranking system. Our system considers the available information about the company and then compares it to all the other stocks we have data on to get a percentile-ranked value. FATE's 53 means that it ranks higher than 53% of stocks.
Who this matters to: Overall Ranking is a comprehensive evaluation. It considers technical and fundamental factors and is a good starting point for evaluating a stock.
FATE Fundamental Analysis
Upgrade to Premium to unlock Fundamental Ranking
FATE Short-Term Technical Analysis
Upgrade to Premium to unlock Short-Term Technical Ranking
FATE Long-Term Technical Analysis
Upgrade to Premium to unlock Long-Term Technical Ranking
FATE Analyst Ranking
Upgrade to Premium to unlock Analyst Ranking Analysis
FATE Valuation Ranking Analysis
Upgrade to Premium to unlock Valuation Ranking
FATE Stock Sentiment Analysis
Upgrade to Premium to unlock Stock Sentiment Ranking
FATE Stock Analysis Overview
What this means: Fate Therapeutics (FATE) gets an Overall Rank of 53, which is an above average rank under InvestorsObserver's stock ranking system. Our system considers the available information about the company and then compares it to all the other stocks we have data on to get a percentile-ranked value. FATE's 53 means that it ranks higher than 53% of stocks.
Who this matters to: Overall Ranking is a comprehensive evaluation. It considers technical and fundamental factors and is a good starting point for evaluating a stock.